Bayesian Capital Management’s Globe Life GL Stock Holding History

Bayesian Capital Management’s Portfolio GL Stock Details GL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,576	Closed	-$339K	–	671
2025 Q1	$339K	Sell	2,576 -3,422	-57%	-$419K	0.06%	363
2024 Q4	$669K	Buy	+5,998	New	+$647K	0.08%	312
2023 Q2	–	Sell	-6,400	Closed	-$704K	–	894
2023 Q1	$704K	Buy	+6,400	New	+$751K	0.09%	308
2022 Q2	–	Sell	-6,517	Closed	-$656K	–	893
2022 Q1	$656K	Buy	+6,517	New	+$661K	0.1%	303
2021 Q2	–	Sell	-2,500	Closed	-$242K	–	493
2021 Q1	$242K	Sell	2,500 -700	-22%	-$67.1K	0.06%	405
2020 Q4	$304K	Buy	+3,200	New	+$285K	0.08%	300
2019 Q1	–	Sell	-7,100	Closed	-$529K	–	629
2018 Q4	$529K	Buy	7,100 +1,200	+20%	+$99.7K	0.11%	271
2018 Q3	$511K	Buy	+5,900	New	+$510K	0.08%	331
2018 Q1	–	Sell	-4,800	Closed	-$435K	–	671
2017 Q4	$435K	Buy	+4,800	New	+$412K	0.09%	350

Other funds holding GL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bayesian Capital Management's GL Position: Q2 2025 in Review

Bayesian Capital Management sold out of Globe Life (GL) in Q2 2025, closing a stake of 2,576 shares — an estimated $339K sold.

Bayesian Capital Management first reported a position in GL in Q4 2017 and held it in 9 quarters. The position peaked at $704K in Q1 2023. 639 funds tracked by Wall St. Rank hold GL as of Q2 2025.

Bayesian Capital Management reported no remaining Globe Life position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 2,576 Globe Life shares in Q2 2025, an estimated $339K.
Bayesian Capital Management first reported a position in Globe Life in Q4 2017 and held it in 9 quarters.
Bayesian Capital Management's Globe Life position peaked at $704K in Q1 2023.
639 funds tracked by Wall St. Rank held Globe Life as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.